Cargando…
Fusion Inhibitory Lipopeptides Engineered for Prophylaxis of Nipah Virus in Primates
BACKGROUND: The emerging zoonotic paramyxovirus Nipah virus (NiV) causes severe respiratory and neurological disease in humans, with high fatality rates. Nipah virus can be transmitted via person-to-person contact, posing a high risk for epidemic outbreaks. However, a broadly applicable approach for...
Autores principales: | Mathieu, Cyrille, Porotto, Matteo, Figueira, Tiago N, Horvat, Branka, Moscona, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6009590/ https://www.ncbi.nlm.nih.gov/pubmed/29566184 http://dx.doi.org/10.1093/infdis/jiy152 |
Ejemplares similares
-
Measles Fusion Machinery Is Dysregulated in Neuropathogenic Variants
por: Jurgens, Eric M., et al.
Publicado: (2015) -
Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides
por: Mathieu, Cyrille, et al.
Publicado: (2017) -
Potency of Fusion-Inhibitory Lipopeptides against SARS-CoV-2 Variants of Concern
por: Schmitz, Katharina S., et al.
Publicado: (2022) -
Intranasal fusion inhibitory lipopeptide prevents direct contact SARS-CoV-2 transmission in ferrets
por: de Vries, Rory D., et al.
Publicado: (2020) -
A General Strategy to Endow Natural Fusion-protein-Derived Peptides with Potent Antiviral Activity
por: Pessi, Antonello, et al.
Publicado: (2012)